Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting

Cited by (480)

Items 101–200 of 480

  1. Surface modification strategies in translocating nano-vesicles across different barriers and the role of bio-vesicles in improving anticancer therapy
    Pratiksha Tiwari, Dr Krishna Yadav, Ravi Prakash Shukla, Shalini Gautam, Disha Marwaha, Madhu Sharma, Prabhat Ranjan Mishra · 2023 · Journal of Controlled Release
  2. Application of engineered extracellular vesicles for targeted tumor therapy
    Fusheng Zhang, J.J. Guo, Zhenghou Zhang, Meiqi Duan, Guang Wang, Yiping Qian, Haiying Zhao, Zhi Yang, Xiaofeng Jiang · 2022 · Journal of Biomedical Science
  3. Extracellular vesicles in cancer´s communication: messages we can read and how to answer
    Alena Semerádtová, Michaela Liegertová, Regina Herma, Magdalena Čapková, Chiara Brignole, Genny Del Zotto · 2025 · Molecular Cancer
  4. Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing
    Frazer Sinclair, Anjuman Ara Begum, Charles C. Dai, István Tóth, Peter Michael Moyle · 2023 · Drug Delivery and Translational Research
  5. Exosomes as Targeted Delivery Platform of CRISPR/Cas9 for Therapeutic Genome Editing
    Duan, Li, Ouyang, Kan, Wang, Jianhong, Xu, Limei, Xu, Xiao, Wen, Caining, Xie, Yixin, Liang, Yujie, Xia, Jiang · 2021 · ChemBioChem
  6. Cardioprotective role of extracellular vesicles: A highlight on exosome beneficial effects in cardiovascular diseases
    Jafar Rezaie, Reza Rahbarghazi‬, Milad Pezeshki, Mahdi Mazhar, Farshid Yekani, Majid Khaksar, Elhameh Shokrollahi, Hassan Amini, Shahriar Hashemzadeh, Sadiye Emel Sokullu et al. · 2019 · Journal of Cellular Physiology
  7. Non-coding RNAs shuttled via exosomes reshape the hypoxic tumor microenvironment
    Wenyu Wang, Youngjin Han, Hyun A. Jo, Juwon Lee, Yong Sang Song · 2020 · Journal of Hematology & Oncology
  8. CRISPR-Cas9 delivery strategies with engineered extracellular vesicles
    Yaoyao Lu, Kelly Godbout, Gabriel Lamothe, Jacques P. Tremblay · 2023 · Molecular Therapy — Nucleic Acids
  9. Targeted nonviral delivery of genome editors in vivo
    Connor A. Tsuchida, Kevin M. Wasko, Jennifer R. Hamilton, Jennifer A. Doudna · 2024 · Proceedings of the National Academy of Sciences
  10. Extracellular Vesicles as Next-Generation Diagnostics and Advanced Therapy Medicinal Products
    Agnieszka Stawarska, Magdalena Bamburowicz‐Klimkowska, Elise Rundén‐Pran, Mária Dušinská, Mihaela Roxana Cimpan, Iván Ríos-Mondragón, Ireneusz P. Grudziński · 2024 · International Journal of Molecular Sciences
  11. Delivery of an Artificial Transcription Regulator dCas9-VPR by Extracellular Vesicles for Therapeutic Gene Activation
    Duško Lainšček, Lucija Kadunc, Mateja Manček Keber, Iva Hafner‐Bratkovič, Rok Romih, Roman Jerala · 2018 · ACS Synthetic Biology
  12. Exosome-mediated RNAi of PAK4 prolongs survival of pancreatic cancer mouse model after loco-regional treatment
    Lizhou Xu, Farid N. Faruqu, Yau Mun Lim, Kee Y. Lim, Revadee Liam‐Or, Adam Alexander Walters, Paul Lavender, David J. Fear, Claire M. Wells, Julie T.-W. Wang et al. · 2020 · Biomaterials
  13. Coassembly of nucleus-targeting gold nanoclusters with CRISPR/Cas9 for simultaneous bioimaging and therapeutic genome editing
    Yu Tao, Ke Yi, Hanze Hu, Dan Shao, Mingqiang Li · 2020 · Journal of Materials Chemistry B
  14. Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma
    Huimin Kong, Enguo Ju, Ke Yi, Weiguo Xu, Yeh‐Hsing Lao, Du Cheng, Qi Zhang, Yu Tao, Mingqiang Li, Jianxun Ding · 2021 · Advanced Science
  15. Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles
    Zhidu Song, Ying Tao, Yue Liu, Jian Li · 2024 · Frontiers in Immunology
  16. Circulating exosomal miRNAs in cardiovascular disease pathogenesis: New emerging hopes
    Amirsaeed Sabeti Aghabozorgi, Najmeh Ahangari, Tasnim Eghbal Eftekhaari, Paria Najarzadeh Torbati, Alireza Bahiraee, Reyhane Ebrahimi, Alireza Pasdar · 2019 · Journal of Cellular Physiology
  17. Phosphatidylcholine‐Engineered Exosomes for Enhanced Tumor Cell Uptake and Intracellular Antitumor Drug Delivery
    Qi Zhan, Kaikai Yi, Xueping Li, Xiaoteng Cui, Eryan Yang, Ning Chen, Xubo Yuan, Jin Zhao, Xin Hou, Chunsheng Kang · 2021 · Macromolecular Bioscience
  18. Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials
    Syed Nasir Abbas Bukhari · 2022 · Pharmaceutics
  19. Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9
    Minse Kim, Youngwoo Hwang, Seongyu Lim, Hyeon‐Ki Jang, Hyun‐Ouk Kim · 2024 · Pharmaceutics
  20. Cell-derived extracellular vesicles for CRISPR/Cas9 delivery: engineering strategies for cargo packaging and loading
    Liang, Yujie, Iqbal, Zoya, Wang, Jianhong, Xu, Limei, Xu, Xiao, Ouyang, Kan, Zhang, Hao, Lu, Jianping, Duan, Li, Xia, Jiang · 2022 · Biomaterials Science
  21. Emerging strategies for labeling and tracking of extracellular vesicles
    Yongjiang Li, Junyong Wu, Jiemin Wang, Xiong-Bin Hu, Daxiong Xiang · 2020 · Journal of Controlled Release
  22. Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications
    Moritz Reese, Sameer Abdallah Dhayat · 2021 · Journal of Hematology & Oncology
  23. 80 years of extracellular vesicles: from discovery to clinical translation
    Qiang Li, Yinan Ding, Yejiao Shi, Chong Qiu, Lei Lei, ShengLong Li, Zheng Zhu, Judun Zheng, Cheng Qin, Kaiyuan Wang et al. · 2026 · Extracellular Vesicles and Circulating Nucleic Acids
  24. γδTDEs: An Efficient Delivery System for miR-138 with Anti-tumoral and Immunostimulatory Roles on Oral Squamous Cell Carcinoma
    Ling Li, Shun Lu, Xin‐hua Liang, Bangrong Cao, Shaoxin Wang, Jian Dong Jiang, Huaichao Luo, Shuya He, Jinyi Lang, Guiquan Zhu · 2018 · Molecular Therapy — Nucleic Acids
  25. Poly(Beta-Amino Ester) Nanoparticles Enable Nonviral Delivery of CRISPR-Cas9 Plasmids for Gene Knockout and Gene Deletion
    Yuan Rui, Mahita Varanasi, Shanelle Mendes, Hannah M. Yamagata, David R. Wilson, Jordan J. Green · 2020 · Molecular Therapy — Nucleic Acids
  26. Recent Advances in Extracellular Vesicles as Drug Delivery Systems and Their Potential in Precision Medicine
    Bart de Jong, Eric Barros, Joost G.J. Hoenderop, Juan Pablo Rigalli · 2020 · Pharmaceutics
  27. A systematic review on the modifications of extracellular vesicles: a revolutionized tool of nano-biotechnology
    Alok Raghav, Goo‐Bo Jeong · 2021 · Journal of Nanobiotechnology
  28. Nanotechnology based CRISPR/Cas9 system delivery for genome editing: Progress and prospect
    Huan Deng, Wei Huang, Zhiping Zhang · 2019 · Nano Research
  29. Tumor-derived extracellular vesicles as messengers of natural products in cancer treatment
    Yuanxin Xu, Kuanhan Feng, Huacong Zhao, Liuqing Di, Lei Wang, Ruoning Wang · 2022 · Theranostics
  30. Engineered extracellular vesicles: potentials in cancer combination therapy
    Jiangbin Chen, Qi Tan, Zimo Yang, Yang Jin · 2022 · Journal of Nanobiotechnology
  31. The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy
    Kewen Qian, Wenyan Fu, Tian Li, Jian Zhao, Changhai Lei, Shi Hu · 2022 · Journal of Experimental & Clinical Cancer Research
  32. Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine
    Daniela Lopes, Joana Lopes, Miguel Pereira‐Silva, Diana Peixoto, Navid Rabiee, Francisco Veiga, Omid Moradi, Zhan-Hu Guo, Xiangdong Wang, João Conde et al. · 2023 · Military Medical Research
  33. Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group
    Alessia Cavazza, Francisco J. Molina-Estévez, Álvaro Plaza Reyes, Víctor Ronco-Díaz, Asma Naseem, Špela Malenšek, Peter Pečan, Annalisa Santini, Paula Heredia, Araceli Aguilar-González et al. · 2025 · Molecular Therapy — Nucleic Acids
  34. Extracellular vesicles for the delivery of gene therapy
    Emilio Di Ianni, Wataru Obuchi, Koen Breyne, Xandra O. Breakefield · 2025 · Nature Reviews Bioengineering
  35. Biomaterial-assisted targeted and controlled delivery of CRISPR/Cas9 for precise gene editing
    Zoya Iqbal, Khurrum Rehman, Jiang Xia, Maryam Shabbir, Muhammad Zaman, Yujie Liang, Li Duan · 2023 · Biomaterials Science
  36. Standardization Approaches for Extracellular Vesicle Loading with Oligonucleotides and Biologics
    Roerig, Josepha, Schulz‐Siegmund, Michaela · 2023 · Small
  37. Exosomes and cancer: From oncogenic roles to therapeutic applications
    Soheila Mohammadi, Fatemeh Yousefi, Zahra Shabaninejad, Ahmad Movahedpour, Maryam Mahjoubin‐Tehran, Alimohammad Shafiee, Sanaz Moradizarmehri, Sarah Hajighadimi, Amir Savardashtaki, Hamed Mirzaei · 2019 · IUBMB Life
  38. Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy
    Ke Yi, Huimin Kong, Yeh‐Hsing Lao, Di Li, Rachel L. Mintz, Tianxu Fang, Guojun Chen, Yu Tao, Mingqiang Li, Jianxun Ding · 2023 · Advanced Materials
  39. Engineering exosomes: a new direction for anticancer treatment.
    Benshuai You, Wenrong Xu, Bin Zhang · 2018 · Europe PMC (PubMed Central)
  40. Extracellular vesicles for improved tumor accumulation and penetration
    Nana Bie, Tuying Yong, Zhaohan Wei, Lu Gan, Xiangliang Yang · 2022 · Advanced Drug Delivery Reviews
  41. Advances in RNA-based cancer therapeutics: pre-clinical and clinical implications
    Yubo Yan, Shuang Liu, Jie Wen, Yunlong He, Chenyang Duan, Noushin Nabavi, Milad Ashrafizadeh, Gautam Sethi, Lubin Liu, Rong Ma · 2025 · Molecular Cancer
  42. Mesenchymal Stem Cell-Derived Extracellular Vesicles for Osteoarthritis Treatment: Extracellular Matrix Protection, Chondrocyte and Osteocyte Physiology, Pain and Inflammation Management
    Thu Huyen Nguyen, Chau Minh Duong, Xuan‐Hung Nguyen, Uyen Thi Trang Than · 2021 · Cells
  43. Bioengineered nanotechnology for nucleic acid delivery
    Yang Zhang, Jing Luo, Xiran Gui, Yating Zheng, Eric Schaar, Gang Liu, Jinjun Shi · 2023 · Journal of Controlled Release
  44. Harnessing exosomes as cancer biomarkers in clinical oncology
    Subhrojyoti Ghosh, Ramya Lakshmi Rajendran, Atharva Anand Mahajan, Ankita Chowdhury, Aishi Bera, Sudeepta Guha, Kashmira Chakraborty, Rajanyaa Chowdhury, Aritra Paul, Shreya Jha et al. · 2024 · Cancer Cell International
  45. Small extracellular vesicles (sEVs): discovery, functions, applications, detection methods and various engineered forms
    Manica Negahdaripour, Hajar Owji, Sedigheh Eskandari, Mozhdeh Zamani, Bahareh Vakili, Navid Nezafat · 2020 · Expert Opinion on Biological Therapy
  46. The in vivo fate and targeting engineering of crossover vesicle-based gene delivery system
    Xinchi Jiang, Tianyuan Zhang, Jianqing Gao · 2022 · Advanced Drug Delivery Reviews
  47. Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy
    Wu Manling, Min Wang, Haoyuan Jia, Peipei Wu · 2022 · Drug Delivery
  48. Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome
    Nasir Uddin, Daniel W. Binzel, Dan Shu, Tian‐Min Fu, Peixuan Guo · 2022 · Acta Pharmaceutica Sinica B
  49. The CRISPR/Cas9 System Delivered by Extracellular Vesicles
    Xinglong Zhu, Mengyu Gao, Yongfeng Yang, Weimin Li, Ji Bao, Yi Li · 2023 · Pharmaceutics
  50. Targeting materials and strategies for RNA delivery
    Lixin Lin, Kexin Su, Qiang Cheng, Shuai Liu · 2023 · Theranostics
  51. Integrated Osteoinductive Factors─Exosome@MicroRNA-26a Hydrogel Enhances Bone Regeneration
    Haizhu Kuang, Jing Ma, Xinyu Chi, Qichen Fu, Qianzhe Zhu, Weiling Cao, Peng Zhang, Xin Xie · 2023 · ACS Applied Materials & Interfaces
  52. Exploiting the Natural Properties of Extracellular Vesicles in Targeted Delivery towards Specific Cells and Tissues
    Pablo Lara, Alan B. Chan, Luis Javier Cruz, Andrew F. G. Quest, Marcelo Javier Kogan · 2020 · Pharmaceutics
  53. Isolation and characterization of extracellular vesicles for clinical applications in cancer – time for standardization?
    Nikki Salmond, Karla C. Williams · 2021 · Nanoscale Advances
  54. Plant Exosomal Vesicles: Perspective Information Nanocarriers in Biomedicine
    Yury Shkryl, Zhargalma Tsydeneshieva, Anton I. Degtyarenko, Yulia Yugay, Larissa Balabanova, Tatiana Rusapetova, Victor P. Bulgakov · 2022 · Applied Sciences
  55. In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications
    Kun Lun Huang, Daniel A. Zapata, Yan Tang, Yong Teng, Yamin Li · 2022 · Biomaterials
  56. Intelligent nanotherapeutic strategies for the delivery of CRISPR system
    Chao Chen, Wu Zhong, Shiyu Du, Yayao Li, Yunfei Zeng, Kunguo Liu, Jingjing Yang, Xiaoxiang Guan, Xin Han · 2022 · Acta Pharmaceutica Sinica B
  57. Advances of engineered extracellular vesicles-based therapeutics strategy
    Hiroaki Komuro, Shakhlo Aminova, Katherine Lauro, Masako Harada · 2022 · Science and Technology of Advanced Materials
  58. Extracellular vesicles biogenesis, isolation, manipulation and genetic engineering for potential in vitro and in vivo therapeutics: An overview
    Nastaran Hadizadeh, Diba Bagheri, Mehdi Shamsara, Michael Richard Hamblin, Abbas Farmany, Mengdi Xu, Zhuobin Liang, Farideh Razi, Ehsan Hashemi · 2022 · Frontiers in Bioengineering and Biotechnology
  59. The emerging roles of exosomal circRNAs in diseases
    Xuan Guo, Wei Tan, Changjun Wang · 2020 · Clinical & Translational Oncology
  60. Delivery systems of CRISPR/Cas9-based cancer gene therapy
    Alessio Biagioni, Anna Laurenzana, Francesca Margheri, Anastasia Chillà, Gabriella Fibbi, Mario Del Rosso · 2018 · Journal of Biological Engineering
  61. Activation of Necroptosis by Engineered Self Tumor-Derived Exosomes Loaded with CRISPR/Cas9
    Diana Gulei, Ioana Berindan‐Neagoe · 2019 · Molecular Therapy — Nucleic Acids
  62. The Emerging Roles of Exosomes in the Chemoresistance of Hepatocellular Carcinoma
    Jie Zhang, Qianqian Song, Mengna Wu, Wenjie Zheng · 2020 · Current Medicinal Chemistry
  63. Hydrogel Loaded with VEGF/TFEB‐Engineered Extracellular Vesicles for Rescuing Critical Limb Ischemia by a Dual‐Pathway Activation Strategy
    Xing Zheng, Chen Fei Zhao, Siwen Wu, Depeng Yang, Chunchen Zhang, Xinbo Wei, Xinran Wei, Haoran Su, Haifeng Liu, Yubo Fan · 2021 · Advanced Healthcare Materials
  64. Gene Therapy Strategies Targeting Aging-Related Diseases
    Jingyu Yu, Tianwen Li, Jianhong Zhu · 2022 · Aging and Disease
  65. Small extracellular vesicle loading systems in cancer therapy: Current status and the way forward
    Yuefeng Zhang, Jin-Bo Shi, Chao Li · 2019 · Cytotherapy
  66. Enrichment of CD44 in Exosomes From Breast Cancer Cells Treated With Doxorubicin Promotes Chemoresistance
    Xiaohong Wang, Kai Cheng, Guoqiang Zhang, yue yu, song liu, yitong hua, Fengli Guo, xiaoqiang li, Zou Weiwei, hongguang sun et al. · 2020 · Frontiers in Oncology
  67. CRISPR: History and perspectives to the future
    Zuzana Kozovská, S. Rajcaniova, P. Munteanu, S. Dzacovska, Lucia Demková · 2021 · Biomedicine & Pharmacotherapy
  68. Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles
    Xiao Cheng, Brian S. Henick, Ke Cheng · 2024 · ACS Nano
  69. Nanovesicle-Mediated Delivery Systems for CRISPR/Cas Genome Editing
    Dongyoon Kim, Quoc‐Viet Le, Yina Wu, Jin-Won Park, Yu‐Kyoung Oh · 2020 · Pharmaceutics
  70. The dynamic, motile and deformative properties of RNA nanoparticles facilitate the third milestone of drug development
    Xin Li, Abhjeet S. Bhullar, Daniel W. Binzel, Peixuan Guo · 2022 · Advanced Drug Delivery Reviews
  71. Exosomes: from basic research to clinical diagnostic and therapeutic applications in cancer
    Salomé Araujo‐Abad, José Marcos Berna, Elena Lloret-Lopez, Andrés López‐Cortés, Miguel Saceda, Camino de Juan Romero · 2024 · Cellular Oncology
  72. Exosomal circular RNA sorting mechanisms and their function in promoting or inhibiting cancer (Review)
    Xiuchao Geng, Xiaomeng Lin, Yuhao Zhang, Qiang Li, Yajing Guo, Chuan Fang, Hong Wang · 2020 · Oncology Letters
  73. Extracellular Vesicles: The Next Generation of Biomarkers and Treatment for Central Nervous System Diseases
    Gabriele Zanirati, Paula Gabrielli dos Santos, Allan Marinho Alcará, Fernanda Thays Konat Bruzzo, Isadora Machado Ghilardi, Vinícius Wietholter, Fernando Antônio Costa Xavier, João Ismael Budelon Gonçalves, Daniel Rodrigo Marinowic, Ashok Kumar Shetty et al. · 2024 · International Journal of Molecular Sciences
  74. CRISPR/Cas System for Genome Editing: Progress and Prospects as a Therapeutic Tool
    Deepak Kumar Sahel, Anupama Mittal, Deepak Chitkara · 2019 · Journal of Pharmacology and Experimental Therapeutics
  75. CRISPR based therapeutics: a new paradigm in cancer precision medicine
    Sumit Das, Shehnaz Bano, Prachi Kapse, Gopal C. Kundu · 2022 · Molecular Cancer
  76. CRISPR delivery with extracellular vesicles: Promises and challenges
    Anne Højberg Berggreen, Julie Lund Petersen, Lin Lin, Karim Benabdellah, Yonglun Luo · 2023 · Journal of Extracellular Biology
  77. Epithelial cell -derived microvesicles: A safe delivery platform of CRISPR/Cas9 conferring synergistic anti-tumor effect with sorafenib
    Cong He, Doulathunnisa Jaffar Ali, Huantian Xu, Subhashree Kumaravel, Ke Si, Yumin Li, Bo Sun, Junqing Ma, Zhongdang Xiao · 2020 · Experimental Cell Research
  78. Pioneer Role of Extracellular Vesicles as Modulators of Cancer Initiation in Progression, Drug Therapy, and Vaccine Prospects
    Sadaf Jahan, Shouvik Mukherjee, Shaheen Ali, Urvashi Bhardwaj, Ranjay Kumar Choudhary, Santhanaraj Balakrishnan, Asma Naseem, Shabir Ahmad Mir, Saeed Banawas, Mohammed Alaidarous et al. · 2022 · Cells
  79. Extracellular Vesicles as Delivery Vehicles for Therapeutic Nucleic Acids in Cancer Gene Therapy: Progress and Challenges
    Rong Du, Chen Wang, Ling Zhu, Yanlian Yang · 2022 · Pharmaceutics
  80. Critical considerations in determining the surface charge of small extracellular vesicles
    Sara Hassanpour Tamrin, Jolene Phelps, Amir Sanati‐Nezhad, Arindom Sen · 2023 · Journal of Extracellular Vesicles
  81. Advances in exosomes utilization for clinical applications in cancer
    Inês A. Batista, José Carlos Machado, Sónia A. Melo · 2024 · Trends in cancer
  82. Exosome-mediated delivery of CRISPR-Cas9: A revolutionary approach to cancer gene editing
    Ashok Kumar Balaraman, Marianesan Arockia Babu, Ehssan H. O. Moglad, Viralkumar B. Mandaliya, M. M. Rekha, Sofia Gupta, G. V. Siva Prasad, Mukesh Kumari, Ashish Singh Chauhan, Haider Ali et al. · 2024 · Pathology - Research and Practice
  83. Cancer Nanomedicines in an Evolving Oncology Landscape
    Peng Guo, Jing Huang, Marsha A. Moses · 2020 · Trends in Pharmacological Sciences
  84. Targeted Delivery of Exosomes Armed with Anti-Cancer Therapeutics
    Hojun Choi, Hwa Young Yim, Cheolhyoung Park, So‐Hee Ahn, Yura Ahn, A-reum Lee, Heekyoung Yang, Chulhee Choi · 2022 · Membranes
  85. Defining tropism and activity of natural and engineered extracellular vesicles
    Wooil Choi, Dong Jun Park, Brian P. Eliceiri · 2024 · Frontiers in Immunology
  86. Local oncolytic adenovirotherapy produces an abscopal effect via tumor-derived extracellular vesicles
    Yoshihiko Kakiuchi, Shinji Kuroda, Nobuhiko Kanaya, Kento Kumon, Tomoko Tsumura, Masashi Hashimoto, Chiaki Yagi, Ryoma Sugimoto, Yuki Hamada, Satoru Kikuchi et al. · 2021 · Molecular Therapy
  87. Breaking barriers in targeted Therapy: Advancing exosome Isolation, Engineering, and imaging
    Anastasiya Kostyusheva, Eugenia Romano, Neng Yan, Manu Lopus, Andrey A. Zamyatnin, Alessandro Parodi · 2025 · Advanced Drug Delivery Reviews
  88. Methods and Challenges in Purifying Drug‐Loaded Extracellular Vesicles
    Marie Auquière, Giulio G. Muccioli, Anne des Rieux · 2025 · Journal of Extracellular Vesicles
  89. A novel dual-targeting delivery system for specific delivery of CRISPR/Cas9 using hyaluronic acid, chitosan and AS1411
    Zahra Khademi, Mohammad Ramezani, Mona Alibolandi, Mohammad Reza Zirak, Zahra Salmasi, Khalil Abnous, Seyed Mohammad Taghdisi · 2022 · Carbohydrate Polymers
  90. Engineered extracellular vesicles mediated CRISPR-induced deficiency of IQGAP1/FOXM1 reverses sorafenib resistance in HCC by suppressing cancer stem cells
    Cong He, Doulathunnisa Jaffar Ali, Yuhua Qi, Yumin Li, Beicheng Sun, Rui Liu, Bo Sun, Zhongdang Xiao · 2023 · Journal of Nanobiotechnology
  91. Recent Advancement and Technical Challenges in Developing Small Extracellular Vesicles for Cancer Drug Delivery
    Tianjiao Geng, Patrick Pan, Euphemia Yee Leung, Qi Chen, Larry Chamley, Zimei Wu · 2021 · Pharmaceutical Research
  92. Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and Challenges
    Saeed Rafii, Emad M. Tashkandi, Nedal Bukhari, Humaid Obaid Al-Shamsi · 2022 · Cancers
  93. The potential role of exosomes derived from ovarian cancer cells for diagnostic and therapeutic approaches
    Changwon Yang, Hee Seung Kim, Gwonhwa Song, Whasun Lim · 2019 · Journal of Cellular Physiology
  94. Role of exosomes in the immune microenvironment of ovarian cancer (Review)
    Li Xiao, Yang Liu, Shuangshuang Zheng, Tianyu Zhang, Jing Wu, Yue Sun, Jingzi Zhang, Guoyan Liu · 2021 · Oncology Letters
  95. Dual-Responsive Core–Shell Tecto Dendrimers Enable Efficient Gene Editing of Cancer Cells to Boost Immune Checkpoint Blockade Therapy
    Junjie Liu, Gaoming Li, Honghua Guo, Cheng Ni, Yue Gao, Xueyan Cao, Jindong Xia, Xiangyang Shi, Rui Guo · 2023 · ACS Applied Materials & Interfaces
  96. Therapeutic applications of CRISPR/Cas9 in breast cancer and delivery potential of gold nanomaterials
    Jananee Padayachee, Moganavelli Singh · 2020 · Nanobiomedicine
  97. Exosomes as Smart Nanoplatforms for Diagnosis and Therapy of Cancer
    Yuying Zhao, Piaoxue Liu, Hanxu Tan, Xiaojia Chen, Qi Wang, Tongkai Chen · 2021 · Frontiers in Oncology
  98. Exosome-based strategies for diagnosis and therapy of glioma cancer
    Mohsen Karami Fath, Jalil Azami, Alireza Masoudi, Reza Mosaddeghi-Heris, Elnaz Rahmani, Fatemeh Alavi, Armina Alagheband Bahrami, Zahra Payandeh, Bahman Khalesi, Masoomeh Dadkhah et al. · 2022 · Cancer Cell International
  99. Current and prospective strategies for advancing the targeted delivery of CRISPR/Cas system via extracellular vesicles
    Xiaowen Huang, Aifang Li, Peng Xu, Yangfan Yu, Shuxuan Li, Lina Hu, Shuying Feng · 2023 · Journal of Nanobiotechnology
  100. Extracellular Vesicles: A New Star for Gene Drug Delivery
    Man Sun, Huan Zhang, Jiayi Liu, Jiayi Chen, Yaxin Cui, Simiao Wang, Xiangyu Zhang, Zhaogang Yang · 2024 · International Journal of Nanomedicine